BridgeBio Oncology Therapeutics, Inc.
BBOT
DELAYED 1 MONTH
8 insider filings · Latest: May 10, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 10, 2026 | May 12 8:12 PM | Idan ElmelechCOO & Principal Financial Ofcr | Grant/Award | 758,222 | $7.66 | 758,222(D) | View → |
| May 10, 2026 | May 12 8:11 PM | Pedro BeltranDirector, President and CEO | Grant/Award | 1,103,837 | $7.66 | 1,103,837(D) | View → |
| Mar 10, 2026 | Mar 12 8:58 PM | Uneek MehraChief Financial Officer | Grant/Award | 105,000 | $10.19 | 105,000(D) | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Pedro BeltranChief Scientific Officer | Grant/Award | 210,000 | $10.19 | 210,000(D) | View → |
| Mar 10, 2026 | Mar 12 8:56 PM | Yong BenChief Med & Dev Officer | Grant/Award | 210,000 | $10.19 | 210,000(D) | View → |